Newcastle University-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Newcastle University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014004
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Newcastle University (NU) is an educational university that offers teaching and research services. The university provides teaching and study services including postgraduate study, undergraduate study, and campus services. It offers teaching services in areas of accounting and finance; agri-business management, agriculture, ancient history, animal science, archaeology, biology and zoology. NU also provides services in business management, chemical engineering, civil engineering, classics and ancient history; computing science, history, journalism, law and others. The university offers research programs in humanities and social sciences; medical sciences, science, agriculture and engineering areas. It also provides accommodation to its students. The university has its operations in Malaysia, Singapore and the UK. NU is headquartered in Newcastle Upon Tyne, the UK.

Newcastle University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Newcastle University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Newcastle University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Newcastle University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Newcastle University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Newcastle University, Medical Devices Deals, 2011 to YTD 2017 9
Newcastle University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Newcastle University, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
QuantuMDx Raises USD8.4 Million in Venture Financing 11
Partnerships 12
DNA2.0 Enters Into Research Agreement With Newcastle University For Bacillus subtillis Expression System 12
Astex Pharma, Cancer Research Technology And Newcastle University Enter Into Drug Discovery Agreement 13
MdxHealth Enters Into Co-Development Agreement With Newcastle University, Cancer Research Technology And Pfizer 15
Licensing Agreements 17
Epistem Holdings and CRT Enter into Licensing Agreement with Newcastle University 17
Newcells Biotech Receives IP Technology Rights from Newcastle University 18
Newcastle University – Key Competitors 19
Newcastle University – Key Employees 20
Newcastle University – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Government and Public Interest 22
Sep 14, 2017: Newcastle researchers awarded £1.7million to investigate heart attack treatments for patients over 75 22
Jul 20, 2017: £2 Million NIHR Award for Newcastle University to Focus on Dementia Care and Prevention on a Global Scale 24
Jun 08, 2016: New safety and efficacy evidence for mitochondrial donation revealed 25
May 19, 2016: New SHIELD to tackle antibiotic resistance 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Newcastle University, Pharmaceuticals & Healthcare, Key Facts 2
Newcastle University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Newcastle University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Newcastle University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Newcastle University, Deals By Therapy Area, 2011 to YTD 2017 8
Newcastle University, Medical Devices Deals, 2011 to YTD 2017 9
Newcastle University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
QuantuMDx Raises USD8.4 Million in Venture Financing 11
DNA2.0 Enters Into Research Agreement With Newcastle University For Bacillus subtillis Expression System 12
Astex Pharma, Cancer Research Technology And Newcastle University Enter Into Drug Discovery Agreement 13
MdxHealth Enters Into Co-Development Agreement With Newcastle University, Cancer Research Technology And Pfizer 15
Epistem Holdings and CRT Enter into Licensing Agreement with Newcastle University 17
Newcells Biotech Receives IP Technology Rights from Newcastle University 18
Newcastle University, Key Competitors 19
Newcastle University, Key Employees 20
Newcastle University, Subsidiaries 21

★海外企業調査レポート[Newcastle University-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Indena SpA:企業の戦略的SWOT分析
    Indena SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Statkraft AS:企業の戦略・SWOT・財務分析
    Statkraft AS - Strategy, SWOT and Corporate Finance Report Summary Statkraft AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Alon USA Energy Inc (ALJ):企業の財務・戦略的SWOT分析
    Alon USA Energy Inc (ALJ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Gulf Investment Corporation:企業の戦略的SWOT分析
    Gulf Investment Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Sisaf Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Sisaf Ltd (Sisaf) is a drug delivery company which designs and develops topical delivery systems for cosmetic, medical, and skin care applications. The company manufactures and markets products and drug delivery solutions using ProSilic, a nano-silicon technology platform. It offers ProSilli …
  • A. Menarini Asia-Pacific Holdings Pte Ltd-製薬・医療分野:企業M&A・提携分析
    Summary A. Menarini Asia-Pacific Holdings Pte Ltd (A. Menarini Asia-Pacific), formerly Invida Group Pte Ltd, a subsidiary of A. Menarini Industrie Farmaceutiche Riunite Srl is a biopharmaceutical company that develops consumer health care products. The company operates through its divisions includin …
  • Comba Telecom Systems Holdings Limited (2342):企業の財務・戦略的SWOT分析
    Comba Telecom Systems Holdings Limited (2342) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Gujarat State Petroleum Corp Ltd:企業の戦略的SWOT分析
    Gujarat State Petroleum Corp Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • THIMM Group GmbH + Co. KG:企業の戦略・SWOT・財務情報
    THIMM Group GmbH + Co. KG - Strategy, SWOT and Corporate Finance Report Summary THIMM Group GmbH + Co. KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Faes Farma SA (FAE):企業の財務・戦略的SWOT分析
    Faes Farma SA (FAE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • China Huaneng Group:企業の発電所・SWOT分析2018
    China Huaneng Group - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • NanoBio Corp-製薬・医療分野:企業M&A・提携分析
    Summary NanoBio Corp (NanoBio) is a biopharmaceutical company that develops vaccines. The company develops and commercializes intranasal and intramuscular vaccines for the prevention and treatment of infectious diseases. The company's vaccines include anthrax, H5 influenza, pertussis, RSV, HIV, HSV- …
  • PT Bank CIMB Niaga Tbk (BNGA)
    PT Bank CIMB Niaga Tbk (BNGA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Quadrise Fuels International Plc (QFI):企業の財務・戦略的SWOT分析
    Quadrise Fuels International Plc (QFI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • AutoZone, Inc.:企業の戦略・SWOT・財務情報
    AutoZone, Inc. - Strategy, SWOT and Corporate Finance Report Summary AutoZone, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Achem Technology Corporation:企業の戦略・SWOT・財務分析
    Achem Technology Corporation - Strategy, SWOT and Corporate Finance Report Summary Achem Technology Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • NutriSystem Inc:企業の戦略的SWOT分析
    NutriSystem Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • WorleyParsons Ltd (WOR):石油・ガス:M&Aディール及び事業提携情報
    Summary WorleyParsons Ltd (WorleyParsons) is a provider of professional services. Its services cover the full lifecycle, from creating new assets to sustaining and enhancing operating assets. The company provides integrated solution for deepwater developments with the associated subsea, pipelines, r …
  • Fanuc Corp (6954):企業の財務・戦略的SWOT分析
    Fanuc Corp (6954) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Gokul Refoils & Solvent Ltd. (GOKULEQ):企業の財務・戦略的SWOT分析
    Gokul Refoils & Solvent Ltd. (GOKULEQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆